Navigation Links
Vicus Therapeutics to Present at the BMO Capital Markets Focus on Healthcare Conference
Date:12/3/2007

MORRISTOWN, N.J., Dec. 3 /PRNewswire/ -- Vicus Therapeutics, LLC, an oncology-focused, clinical-stage biopharmaceutical company, announced today that Chief Executive Officer, John Maki, will present at the BMO Capital Markets Focus on Healthcare Conference. The presentation will be held on December 4, 2007 at 1:30 p.m. ET at the Millennium Broadway Hotel in New York City.

About Vicus Therapeutics

Vicus Therapeutics is a privately-held, biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of cancer supportive care indications with an initial focus on cachexia. Vicus' strategy involves combining individual generic drugs that have previously received regulatory approval for other indications and thus have established post-marketing safety records. Vicus leverages its proprietary science to design and patent novel drug combinations that work together to reverse the body's maladaptive responses to cancer and its treatment. Vicus' lead combination product candidate, VT-122, is in Phase 2 clinical trials for the treatment of cancer cachexia in patients with advanced lung cancer. Additionally, Vicus has preclinical-stage combination product candidates being evaluated for the treatment of oral mucositis and cancer fatigue. Vicus' development programs are powered by its network of leading clinical investigators and partners in the US, India and Japan. This international network drives the high quality, rapid and cost effective clinical development of Vicus' product candidates. For additional information, go to the Company's website: http://www.vicustherapeutics.com.


'/>"/>
SOURCE Vicus Therapeutics
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Vicus Therapeutics Chief Executive Officer to Participate in BIOTECH 2007 Expert Panels
3. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
4. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
5. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
6. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
7. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
8. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
9. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
10. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
11. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... MA (PRWEB) October 31, 2014 Following ... hosting a free learning webinar to introduce its new ... standards directors and biostatisticians. , Launched in September, Formedix ... company's suite of clinical trial automation tools. For the ... a web browser. And by introducing Formations – a ...
(Date:10/31/2014)... York, NY (PRWEB) October 31, 2014 ... such as healthcare, construction, finance and consumer electronics ... For this reason, industry research firm IBISWorld has ... industry to its growing industry report collection. , ... develop software for biometric technologies such as fingerprint, ...
(Date:10/30/2014)... FREMONT, Calif. , Oct. 30, 2014 /PRNewswire/ ... clinical-stage biopharmaceutical company focused on cardio-renal, gastrointestinal and ... third quarter 2014 financial results on Thursday, November ... team will host a live conference call and ... financial results and provide a business update. ...
(Date:10/30/2014)... Diego, CA (PRWEB) October 30, 2014 ... announced today that they have manually curated public data ... and non profit customers. the data is now ... manually curates and unifies public and internal data sources ... value and knowledge out of the data that becomes ...
Breaking Biology Technology:Formedix to Introduce "Revolutionary" Clinical Trial Automation Software with Learning Webinar 2Biometrics Scan Software in the US Industry Market Research Report Now Available from IBISWorld 2Biometrics Scan Software in the US Industry Market Research Report Now Available from IBISWorld 3Ardelyx to Report Third Quarter 2014 Financial Results on November 6, 2014 2Rancho BioSciences Manually Curated TCGA Data Sets Available 2
... SectorWatch.biz announces the,availability of MarketStats on ... today within the biotechnology and diagnostic testing ... equities and the,opportunity for investors to respond ... sector., Investors can view SectorWatch.biz MarketStats ...
... proprietary Derma product to 32,000+ healthcare providers, ... Bulletin Board: DSCI), a provider of advanced wound ... new multi-year supply,agreement with one of the nation,s ... MedAssets company (Nasdaq: MDAS ). The,3-year agreement, ...
... Wednesday, April 30, at 1:00 p.m. ET, ... AVGN ), a biopharmaceutical company innovating therapeutics ... to discuss first,quarter results on Wednesday, April 30, ... Chahine, Chief Executive Officer, and Michael Coffee, Chief,Business ...
Cached Biology Technology:SectorWatch.biz Issues MarketStats on KBLB, DGX, LH, BRLI, and ABT 2SectorWatch.biz Issues MarketStats on KBLB, DGX, LH, BRLI, and ABT 3Derma Sciences Announces Agreement With MedAssets for MEDIHONEY(TM) Wound & Burn Dressings 2Derma Sciences Announces Agreement With MedAssets for MEDIHONEY(TM) Wound & Burn Dressings 3Derma Sciences Announces Agreement With MedAssets for MEDIHONEY(TM) Wound & Burn Dressings 4Avigen, Inc. Announces First Quarter 2008 Earnings Conference Call 2
(Date:10/29/2014)... factors, both genetic and environmental, have been blamed ... schizophrenia. Some, such as a family history of ... with Toxoplasma gondii , a parasite transmitted ... still viewed with skepticism. , A new study ... epidemiology at the University of Pennsylvania,s School of ...
(Date:10/29/2014)... safety of nanoparticles is all the rage. Thousands of ... the question of whether titanium dioxide nanoparticles from sun ... body, whether carbon nanotubes from electronic products are as ... or whether nanoparticles in food can get into the ... is great, research funds are flowing – and the ...
(Date:10/29/2014)... release is available in German . ... another: Gabriela Cabral and Peter Schlögelhofer at the Max ... and the Medical University of Vienna dived into the ... that these plants display an inversion of the standard ... the scientific journal Nature Communications . , Meiosis ...
Breaking Biology News(10 mins):Penn vet professor investigates parasite-schizophrenia connection 2Penn vet professor investigates parasite-schizophrenia connection 3Nanosafety research: The quest for the gold standard 2Nanosafety research: The quest for the gold standard 3Meiotic cell division 'the other way round' 2
... of 2009 did not continue into 2010. While the three ... more than $40 billion, only last year,s top purchase got ... conducted by Genetic Engineering & Biotechnology News (GEN) ( http://www.genengnews.com/ ... move to buy Genzyme, is still being worked out. ...
... low in oxygen long have been thought to have ... study shows that while these so-called dead zones have ... Tomas Höök, an assistant professor of forestry and ... used output from a model to estimate how much ...
... Symposium, a new forum for the best pre-clinicaland translational ... March 22-23, 2011, immediately preceding the European Congress on ... be chaired by Gerard Karsenty, Professor and Chair, Genetics ... world,s leading scientists from the bone biology arena. All ...
Cached Biology News:GEN reports on biotech acquisition deals in 2010 that topped $1 billion 2Lake Erie hypoxic zone doesn't affect all fish the same, study finds 2
Request Info...
NovaScreen offers cell biology, cell culture and molecular biology services for companies who lack a cell culture facility....
... Service The Human Genetic Cell Bank ... (EBV) immortalisation of human peripheral blood lymphocytes ... cell lines (LCLs). These cell lines are ... source of genomic DNA and RNA. ...
... Application: The Panorama Mouse/Rat Tissue Extract Protein ... expression in various tissue extracts. The expression ... detected using a protein specific antibody. When ... is visualized by a sensitive chemiluminescent or ...
Biology Products: